In last trading session, Revelation Biosciences Inc (NASDAQ:REVB) saw 1.13 million shares changing hands with its beta currently measuring -0.06. Company’s recent per share price level of $0.82 trading at -$0.02 or -2.26% at ring of the bell on the day assigns it a market valuation of $1.66M. That closing price of REVB’s stock is at a discount of -6729.27% from its 52-week high price of $56.00 and is indicating a premium of 9.76% from its 52-week low price of $0.74. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.44 million shares which gives us an average trading volume of 1.03 million if we extend that period to 3-months.
For Revelation Biosciences Inc (REVB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Revelation Biosciences Inc (NASDAQ:REVB) trade information
Upright in the red during last session for losing -2.26%, in the last five days REVB remained trading in the green while hitting it’s week-highest on Thursday, 06/26/25 when the stock touched $0.82 price level, adding 16.33% to its value on the day. Revelation Biosciences Inc’s shares saw a change of -97.86% in year-to-date performance and have moved 3.20% in past 5-day. Revelation Biosciences Inc (NASDAQ:REVB) showed a performance of -63.88% in past 30-days. Number of shares sold short was 0.15 million shares which calculate 0.06 days to cover the short interests.
In 2025, company’s earnings growth rate is likely to be around 76.23% while estimates for its earnings growth in next 5 years are of 72.37%.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
Insiders are in possession of 2.27% of company’s total shares while institution are holding 3.17 percent of that, with stock having share float percentage of 3.24%. Investors also watch the number of corporate investors in a company very closely, which is 3.17% institutions for Revelation Biosciences Inc that are currently holding shares of the company.
